Celebrating the founding of Sanofi's future Evolutive Vaccines Facility (EVF) production unit (L-R): CEO Paul Hudson; Olivier Véran, Minister of Health; Frédérique Vidal, Minister of Higher Education, Research and Innovation; Jean Castex, Prime Minister; Agnès Pannier-Runacher, Minister of Industry; Eric Bellot, Mayor of Neuville-sur-Saône (courtesy Sanofi)

Sanofi CEO Paul Hud­son sketch­es a $1B-plus in­vest­ment on its new mR­NA cen­ter

Over the years, Paris-based Sanofi has had a com­plex re­la­tion­ship with its home coun­try of France. One for­mer CEO (Chris Viehbach­er) seemed to en­joy prod­ding the coun­try’s R&D work­force for a lack of pro­duc­tiv­i­ty — un­til the board chose a French­man (Olivi­er Brandi­court) to re­place him. If on­ly tem­porar­i­ly.

But CEO Paul Hud­son, an ur­bane British ex­ec­u­tive with a glob­al ré­sumé, is mak­ing him­self quite at home in the Eu­ro­pean coun­try.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.